Macular degeneration Trials in Fort Myers, United States
Conditions / Macular degeneration / Fort Myers, United States
Macular degeneration is a medical condition with active clinical research programs worldwide.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03815825 | GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) | COMPLETED | PHASE2 |
| NCT00509795 | Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) | COMPLETED | PHASE3 |
| NCT00061594 | A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration | COMPLETED | PHASE3 |
| NCT01134055 | Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration | COMPLETED | PHASE2 |
| NCT03894020 | GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) | TERMINATED | — |
| NCT02462928 | A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | COMPLETED | PHASE3 |
| NCT02348359 | X-82 to Treat Age-related Macular Degeneration | TERMINATED | PHASE2 |
| NCT02462486 | Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | COMPLETED | PHASE3 |
| NCT04435366 | A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) | COMPLETED | PHASE3 |
| NCT02222207 | Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration | TERMINATED | PHASE2 |